Removal of nonimpacted third molars alters the periodontal condition of their neighbors clinically, immunologically, and microbiologically

Abstract

Considering the adverse effects of nonimpacted third molars (N-M3s) on the periodontal health of adjacent second molars (M2s), the removal of N-M3s may be beneficial to the periodontal health of their neighbors. This study aimed to investigate the clinical, immunological, and microbiological changes of the periodontal condition around M2s following removal of neighboring N-M3s across a 6-month period. Subjects with at least one quadrant containing an intact first molar (M1), M2, and N-M3 were screened and those who met the inclusion criteria and decided to receive N-M3 extraction were recruited in the following investigation. M2 periodontal condition was interrogated before M3 extraction (baseline) and at 3 and 6 months postoperatively. Improvements in clinical periodontal indexes of M2s in response to their adjacent N-M3 removal, along with changes in inflammatory biomarkers among gingival crevicular fluid (GCF) and the composition of subgingival plaque collected from the distal sites of the M2s of the targeted quadrant were parallelly analyzed. Complete data of 26 tooth extraction patients across the follow-up period were successfully obtained and subsequently applied for statistical analysis. Compared to the baseline, the periodontal condition of M2s was significantly changed 6 months after N-M3 removal; specifically, the probing depth of M2s significantly reduced (P < 0.001), the matrix metalloproteinase (MMP)-8 concentration involved in GCF significantly decreased (P = 0.025), and the abundance of the pathogenic genera unidentified Prevotellaceae and Streptococcus significantly decreased (P < 0.001 and P = 0.009, respectively). We concluded that N-M3 removal was associated with superior clinical indexes, decreased GCF inflammatory biomarkers, and reduced pathogenic microbiome distribution within the subgingival plaque. Although the retention or removal of N-M3s continues to be controversial, our findings provide additional evidence that medical decisions should be made as early as possible or at least before the neighboring teeth are irretrievably damaged.

References

[1] Haug RH, Abdul-Majid J, Blakey GH, White RP. Evidenced-based decision making: the third molar. Dent. Clin. North Am., 2009, 53: 77-96, ix.

[2] Steed MB. The indications for third-molar extractions. J. Am. Dent. Assoc., 2014, 145: 570-573.

[3] Nunn ME, . Retained asymptomatic third molars and risk for second molar pathology. J. Dent. Res., 2013, 92: 1095-1099.

[4] Venta I, Vehkalahti MM, Suominen AL. What kind of third molars are disease-free in a population aged 30 to 93 years?. Clin. Oral. Investig., 2019, 23: 1015-1022.

[5] Kindler S, . Third molars and periodontal damage of second molars in the general population. J. Clin. Periodontol., 2018, 45: 1365-1374.

[6] Li ZB, Qu HL, Zhou LN, Tian BM, Chen FM. Influence of non-impacted third molars on pathologies of adjacent second molars: a retrospective study. J. Periodontol., 2017, 88: 450-456.

[7] Chou YH, Ho PS, Ho KY, Wang WC, Hu KF. Association between the eruption of the third molar and caries and periodontitis distal to the second molars in elderly patients. Kaohsiung J. Med. Sci., 2017, 33: 246-251.

[8] Li ZB, . Nonimpacted third molars affect the periodontal status of adjacent teeth: a cross-sectional study. J. Oral. Maxillofac. Surg., 2017, 75: 1344-1350.

[9] Qu HL, . Effect of asymptomatic visible third molars on periodontal health of adjacent second molars: a cross-sectional study. J. Oral. Maxillofac. Surg., 2017, 75: 2048-2057.

[10] Passarelli PC, . Influence of mandibular third molar surgical extraction on the periodontal status of adjacent second molars. J. Periodontol., 2019, 90: 847-855.

[11] Sun LJ, . Impacts of non-impacted third molar removal on the periodontal condition of adjacent second molars. Oral. Dis., 2020, 26: 1010-1019.

[12] Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat. Rev. Dis. Prim., 2017, 3: 17038.

[13] Petsos H, Korte J, Eickholz P, Hoffmann T, Borchard R. Surgical removal of third molars and periodontal tissues of adjacent second molars. J. Clin. Periodontol., 2016, 43: 453-460.

[14] Pham TAV, Nguyen NH. Periodontal status of the adjacent second molar after impacted mandibular third molar surgical extraction. Contemp. Clin. Dent., 2019, 10: 311-318.

[15] Fisher EL, Blakey GH, Offenbacher S, Phillips C, White RP Jr. Mechanical debridement of subgingival biofilm in participants with asymptomatic third molars does not reduce deeper probing depths in the molar regions of the mouth. J. Oral. Maxillofac. Surg., 2013, 71: 467-474.

[16] Mansfield JM, Campbell JH, Bhandari AR, Jesionowski AM, Vickerman MM. Molecular analysis of 16S rRNA genes identifies potentially periodontal pathogenic bacteria and archaea in the plaque of partially erupted third molars. J. Oral. Maxillofac. Surg., 2012, 70: 1507-1514 e1501-1506.

[17] White RP Jr, . Microbial complexes detected in the second/third molar region in patients with asymptomatic third molars. J. Oral. Maxillofac. Surg., 2002, 60: 1234-1240.

[18] White RP Jr, . Inflammatory mediators and periodontitis in patients with asymptomatic third molars. J. Oral. Maxillofac. Surg., 2002, 60: 1241-1245.

[19] Stadler AF, . Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis. J. Clin. Periodontol., 2016, 43: 727-745.

[20] Tsuchida, S., Satoh, M., Takiwaki, M. & Nomura, F. Current status of proteomic technologies for discovering and identifying gingival crevicular fluid biomarkers for periodontal disease. Int. J. Mol. Sci. 20, 86 (2018).

[21] Alassy, H., Parachuru, P. & Wolff, L. Peri-implantitis diagnosis and prognosis using biomarkers in peri-implant crevicular fluid: a narrative review. Diagnostics. 9, 214 (2019).

[22] Almehmadi AH, Alghamdi F. Biomarkers of alveolar bone resorption in gingival crevicular fluid: a systematic review. Arch. Oral. Biol., 2018, 93: 12-21.

[23] Nazar Majeed Z, Philip K, Alabsi AM, Pushparajan S, Swaminathan D. Identification of gingival crevicular fluid sampling, analytical methods, and oral biomarkers for the diagnosis and monitoring of periodontal diseases: a systematic review. Dis. Markers, 2016, 2016: 1804727.

[24] Cheng R, Wu Z, Li M, Shao M, Hu T. Interleukin-1beta is a potential therapeutic target for periodontitis: a narrative review. Int. J. Oral. Sci., 2020, 12: 2.

[25] Costa FO, . Cytokine levels in crevicular fluid associated with compliance during periodontal maintenance therapy. Clin. Oral. Investig., 2019, 23: 3517-3526.

[26] Konopka L, Pietrzak A, Brzezinska-Blaszczyk E. Effect of scaling and root planing on interleukin-1beta, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients. J. Periodontal Res., 2012, 47: 681-688.

[27] Sorsa T, . Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontology, 2016, 70: 142-163.

[28] Boelen GJ, . Matrix metalloproteinases and inhibitors in dentistry. Clin. Oral. Investig., 2019, 23: 2823-2835.

[29] Rathnayake N, . Salivary biomarkers of oral health: a cross-sectional study. J. Clin. Periodontol., 2013, 40: 140-147.

[30] Chen YW, Hsieh O, Chen YA, Chiou LL, Chang PC. Randomized controlled clinical effectiveness of adjunct 660-nm light-emitting diode irradiation during non-surgical periodontal therapy. J. Formos. Med. Assoc., 2020, 119: 157-163.

[31] Chiang CP, Hsieh O, Tai WC, Chen YJ, Chang PC. Clinical outcomes of adjunctive indocyanine green-diode lasers therapy for treating refractory periodontitis: a randomized controlled trial with in vitro assessment. J. Formos. Med. Assoc., 2020, 119: 652-659.

[32] Emingil G, . Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy. J. Periodontol., 2014, 85: 1070-1080.

[33] Turkoglu O, . The effect of adjunctive chlorhexidine mouthrinse on GCF MMP-8 and TIMP-1 levels in gingivitis: a randomized placebo-controlled study. BMC Oral. Health, 2014, 14

[34] Ince G, . Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J. Periodontol., 2015, 86: 746-754.

[35] Schmalz G, . MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - first results of a cross-sectional study. J. Microbiol. Immunol. Infect., 2019, 52: 386-394.

[36] Ayravainen L, . Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease. Oral. Dis., 2018, 24: 1562-1571.

[37] Teixeira MKS, . The modulation of the TREM-1/PGLYRP1/MMP-8 axis in peri-implant diseases. Clin. Oral. Investig., 2020, 24: 1837-1844.

[38] Graziani F, . Systemic inflammation after third molar removal: a case-control study. J. Dent. Res., 2017, 96: 1505-1512.

[39] Camacho-Alonso F, . Salivary myeloperoxidase and malondialdehyde are increased in patients exhibiting an asymptomatic mandibular impacted third molar. Med. Oral. Patol. Oral. Cir. Bucal, 2019, 24: e537-e544.

[40] Camelo-Castillo A, . Relationship between periodontitis-associated subgingival microbiota and clinical inflammation by 16S pyrosequencing. J. Clin. Periodontol., 2015, 42: 1074-1082.

[41] Chen WP, . Composition analysis and feature selection of the oral microbiota associated with periodontal disease. Biomed. Res. Int., 2018, 2018: 3130607.

[42] Shen LH, Xiao E, Wang EB, Zheng H, Zhang Y. High-throughput sequencing analysis of microbial profiles in the dry socket. J. Oral. Maxillofac. Surg., 2019, 77: 1548-1556.

[43] Menon RK, . Long-term impact of oral surgery with or without amoxicillin on the oral microbiome—a prospective cohort study. Sci. Rep., 2019, 9

[44] Shi M, . The subgingival microbiome of periodontal pockets with different probing depths in chronic and aggressive periodontitis: a pilot study. Front. Cell Infect. Microbiol., 2018, 8: 124.

[45] Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch. Microbiol., 2018, 200: 525-540.

[46] Zaura E, Keijser BJ, Huse SM, Crielaard W. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol., 2009, 9: 259.

[47] Arredondo A, Blanc V, Mor C, Nart J, Leon R. Azithromycin and erythromycin susceptibility and macrolide resistance genes in Prevotella from patients with periodontal disease. Oral. Dis., 2019, 25: 860-867.

[48] Koychev S, Dommisch H, Chen H, Pischon N. Antimicrobial effects of mastic extract against oral and periodontal pathogens. J. Periodontol., 2017, 88: 511-517.

[49] Perez-Chaparro PJ, . Newly identified pathogens associated with periodontitis: a systematic review. J. Dent. Res., 2014, 93: 846-858.

[50] Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol., 1998, 25: 134-144.

[51] Belstrom D, . Influence of periodontal treatment on subgingival and salivary microbiotas. J. Periodontol., 2018, 89: 531-539.

[52] Liu G, . Shift in the subgingival microbiome following scaling and root planing in generalized aggressive periodontitis. J. Clin. Periodontol., 2018, 45: 440-452.

[53] Ikeda E, . Deep sequencing reveals specific bacterial signatures in the subgingival microbiota of healthy subjects. Clin. Oral. Investig., 2019, 23: 1489-1493.

[54] Correa FOB, Goncalves D, Figueredo CMS, Gustafsson A, Orrico SRP. The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis. J. Periodontol., 2008, 79: 2143-2150.

Funding

National Science Foundation of China | Major Research Plan(81991503, 81991503, 81991503, 81991503, 81991503)

Shaanxi Key Scientific and Technological Innovation Team (2017KCT-32)